11-57600288-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000062.3(SERPING1):c.461A>G(p.Tyr154Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y154S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000062.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary angioedema with C1Inh deficiencyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- C1 inhibitor deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary angioedema type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary angioedema type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary angioedema type 1 Pathogenic:1
According to our observation and published information (López-Lera et all, 2011 and Xu et al., 2012) the c.461A>G variant in SERPING1 meets ACMG/ClinGen SVI guidance criteria to be classified as pathogenic: PP3_Mod, PS4_Mod, PP4_Mod, PM2_Sup, PP2 -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at